NCT04321941View on ClinicalTrials.gov

Trial Evaluating the Diagnostic Usefulness of Lumentin® 44 When Used as Contrast Agent

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 29, 2020

Primary Completion Date

April 4, 2022

Study Completion Date

May 12, 2022

Conditions
Crohn Disease
Interventions
DIAGNOSTIC_TEST

Lumentin

Contrast agent used in combination with CTE

DIAGNOSTIC_TEST

Movprep

Contrast agent used in combination with MRE

Trial Locations (1)

20502

Department of medical imaging and function, Malmo

Sponsors

Collaborators (1)

LINK Medical Research
All Listed Sponsors
collaborator

LINK Medical Research

UNKNOWN

lead

Lument AB

INDUSTRY